Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal De Pharmacologie|January 1, 1985
Effects of Hydergine and its components on Lashley maze acquisition in ratsA L Jaton, J M VigouretJournal De Physiologie|January 1, 1981
[Involvement of serotoninergic mechanisms in the circling behaviour induced by apomorphine and LSD 25 in rats (author's transl)]A L Jaton, J M Vigouret, A DravidNeuroscience Letters|May 16, 1988
Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned ratsG Karlsson, A L Jaton, J M VigouretBritish Journal of Pharmacology|January 1, 1976
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPAA M Johnson, D M Loew, J M VigouretExperientia|May 15, 1978
Inhibition of reserpine-induced PGO waves in the cat by ergot derivativesP E Züger, J M Vigouret, D M LoewJournal of Medicinal Chemistry|August 1, 1978
Ergot alkaloids. New ergolines as selective dopaminergic stimulantsP L Stütz, P A Stadler, J M Vigouret, et al.Pharmacology|January 1, 1978
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712J M Vigouret, H R Bürki, A L Jaton, et al.Journal of Neural Transmission|January 1, 1987
Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8 beta-ergoleneR Markstein, A Enz, J M Vigouret, et al.Experientia|October 15, 1987
A new semisynthetic ergot peptide alkaloid: DCN 203-922R K Giger, H R Loosli, M D Walkinshaw, et al.Pageof 2